Frontlight ResearchEarly access
CompletedPhase 4
Immune Response to High-Dose vs. Standard Dose Influenza Vaccine
Key facts
- Who runs it
- Health Sciences North Research Institute
- Where
- Farmington, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 393 people enrolled
- Started
- 1 Feb 2014
- Ended
- 21 Sept 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Flu Vaccine
- Record updated
- 5 October 2026
Who can take part
- Age
- 20 years and older
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 8 criteriaShow less
Who can take part
- Written informed consent provided by the participant
- Age 20-40 years old with no underlying chronic diseases or age ≥65 years old
- Willing to receive influenza vaccination
- Older cohort has received their influenza vaccine for the previous influenza season; -
Who cannot take part
- Have not received influenza vaccination in the past or cannot be vaccinated due to previous severe reaction to influenza vaccine, egg, latex, or thimerosol allergies, or refusal of vaccination
- Participant has received a community available influenza vaccine for the approaching influenza season
- Immunosuppressive disorders or medications (including oral prednisone in doses >10 mg daily)
- Females who are pregnant at Visit 1 (a pregnancy test will be administered for all females of child-bearing potential); -
Where in United States
Also in 1 other country, 1 site
- Center on Aging, UConn HealthFarmington, United States
About the trial
What the trial wants to find out
This 5-year proposal is a randomized study of split-virus influenza vaccine (SVV) in a high-dose (HD) vs. standard-dose (SD) formulation in each of five influenza seasons to define the key determinants of vaccine-mediated protection against influenza and how these immunologic mediators may be enhanced by vaccination with a newly approved high-dose influenza vaccine in older people
The 2 groups in the trial
- Flu Vaccine SDExisting treatment, for comparison
Fluzone Standard Dose Influenza Vaccine
Treatment: Flu Vaccine
- Flu Vaccine HDExisting treatment, for comparison
Fluzone High Dose Influenza Vaccine
Treatment: Flu Vaccine
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Publications
- Record updated
- 5 October 2026